Phase 4 Atrial Fibrillation Trial, Recruiting (NCT03868150)

Phase 4 Atrial Fibrillation Trial, Recruiting NCT03868150 Sponsor: Stanford University Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT03868150 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People scheduled for their first planned (non-emergency) open-heart surgery, such as coronary artery bypass grafting (heart bypass surgery), heart valve repair or replacement, a combination of bypass and valve surgery, or a type of aortic root repair that preserves the valve
People whose heart is beating in a normal, regular rhythm
People with no recorded history of an irregular heartbeat condition called atrial fibrillation

Who may not be able to join:

People who have previously had open-heart surgery involving the use of a heart-lung (cardiopulmonary bypass) machine
People with any recorded history of atrial fibrillation, atrial flutter, or a rapid heart rhythm originating in the upper chambers of the heart that lasted longer than 30 seconds
People who have previously been treated with a medication called Amiodarone for managing certain types of fast, irregular heartbeats
People whose planned surgery includes a procedure to treat irregular heartbeats, such as pulmonary vein isolation or a Maze procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Anson Lee, MD, Stanford University

Phone: 650-724-7500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03868150

Sponsor: Stanford University

Phase: Phase 4

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 650-724-7500

More information: https://clinicaltrials.gov/study/NCT03868150

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People scheduled for their first planned (non-emergency) open-heart surgery, such as coronary artery bypass grafting (heart bypass surgery), heart valve repair or replacement, a combination of bypass and valve surgery, or a type of aortic root repair that preserves the valve
People whose heart is beating in a normal, regular rhythm
People with no recorded history of an irregular heartbeat condition called atrial fibrillation

Who may not be able to join:

People who have previously had open-heart surgery involving the use of a heart-lung (cardiopulmonary bypass) machine
People with any recorded history of atrial fibrillation, atrial flutter, or a rapid heart rhythm originating in the upper chambers of the heart that lasted longer than 30 seconds
People who have previously been treated with a medication called Amiodarone for managing certain types of fast, irregular heartbeats
People whose planned surgery includes a procedure to treat irregular heartbeats, such as pulmonary vein isolation or a Maze procedure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

1 March 2017

Est. completion

31 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Decreasing the incidence of Post-Operative Atrial Fibrillation for Cardiac Surgery Patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov